ADK and metabolic dysfunction-associated steatotic liver disease: Given this, it would be interesting to determine the extent to which ADK-driven hepatocyte proinflammatory responses, but not macrophage-stimulated inflammation, serve as a predominant contributor exacerbating liver inflammation during the late stage of MASLD including liver fibrosis in the future study.